Nightmare < Nigrostriatal pathway < Nitric oxide

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]

Ident.	Authors (with country if any)	Title
000032 (2014)	N. Daviaud [France] ; E. Garbayo [France, Espagne] ; N. Lautram [France] ; F. Franconi [France] ; L. Lemaire [France] ; M. Perez-Pinzon [États-Unis] ; C. N. Montero-Menei [France]	MODELING NIGROSTRIATAL DEGENERATION IN ORGANOTYPIC CULTURES, A NEW EX VIVO MODEL OF PARKINSON'S DISEASE
000033 (2014)	G. Drui [France] ; S. Carnicella [France] ; C. Carcenac [France] ; M. Favier [France] ; A. Bertrand [France] ; S. Boulet [France] ; M. Savasta [France]	Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
000359 (2011)	Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France]	Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration
000575 (2009)	Anne Vital [France] ; Pierre-Olivier Femagut [France] ; Marie-Hélène Canron [France] ; Julien Joux [France] ; Erwan Bezard [France] ; Marie-Laure Martin-Negrier [France] ; Claude Vital [France] ; François Tison [France]	The Nigrostriatal Pathway in Creutzfeldt-Jakob Disease
000748 (2008)	Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]	MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations
000795 (2008)	Margarete Zanardo Gomes [Brésil] ; Rita Raisman-Vozari [France] ; Elaine A. Del Bel [Brésil]	A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway
000896 (2007)	S. Breit [France, Allemagne] ; R. Bouali-Benazzouz [France] ; R. C. Popa [Allemagne] ; T. Gasser [Allemagne] ; A. L. Benabid [France] ; A. Benazzouz [France]	Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat
000B04 (2005)	R. Robichon [France] ; A. Jaafar [France] ; M. Terqui [France] ; P. Brachet [France] ; M. Peschanski [France]	Pig xenografts to the immunocompetent rat brain : Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains
000B31 (2005)	Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France]	Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus
000C18 (2004)	Howard T. J. Mount [Canada] ; Jean-Claude Martel [France] ; Paul Fluit [Canada] ; YINGJI WU [Canada] ; Eleanor Gallo-Hendrikx [Canada] ; Cristina Cosi [France] ; Marc R. Marien [France]	Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia
000C53 (2004)	Juan E. Ferrario [Argentine] ; Irene R. E. Taravini [Argentine] ; Sophie Mourlevat [France] ; Andrea Stefano [Argentine] ; Marina A. Delfino [Argentine] ; Rita Raisman-Vozari [France] ; M. Gustavo Murer [Argentine] ; Merle Ruberg [France] ; Oscar Gershanik [Argentine]	Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system
000C95 (2003)	Ph. Remy [France] ; Z. Malek [France] ; E. Itti [France]	Mise en évidence de la perte des neurones dopaminergiques nigro-striataux par la scintigraphie cérébrale au [123I]-Ioflupane (DatScan®) : Principes et applications : Formation post-universitaire
000E93 (2002)	Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France]	Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat
000E95 (2002)	T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France]	Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
001042 (2001)	J.-C. Lievens [France] ; P. Salin [France] ; A. Nieoullon [France] ; L. Kerkerian-Le Goff [France]	Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum
001170 (2000)	Z. G. Ni [France] ; D. M. Gao [République populaire de Chine] ; A. L. Benabid [France] ; A. Benazzouz [France]	Unilateral lesion of the nigrostriatal pathway induces a transient decrease of firing rate with no change in the firing pattern of neurons of the parafascicular nucleus in the rat
001171 (2000)	E. Aliaga [Chili] ; C. Carcamo [Chili] ; J. Abarca [Chili] ; L. Tapia-Arancibia [France] ; G. Bustos [Chili]	Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway
001189 (2000)	E. C. Hirsch [France] ; BENABID ; OLANOW ; SEALFON ; HALLETT ; LANGSTON ; CALABRESI	Nigrostriatal system plasticity in Parkinson's disease : Effect of dopaminergic denervation and treatment. Discussion
001192 (2000)	Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse]	Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
001214 (2000)	C. Perier [France] ; M. Vila [France] ; J. Feger [France] ; Yves Agid [France] ; E. C. Hirsch [France]	Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
001232 (2000)	C. Scherfler [Autriche] ; Z. Puschban [Autriche] ; I. Ghorayeb [France] ; G. P. Goebel [Autriche] ; F. Tison [France] ; K. Jellinger [Autriche] ; Werner Poewe [Autriche] ; G. K. Wenning [Autriche]	Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Nigrostriatal pathway" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Nigrostriatal pathway" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Nigrostriatal pathway
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024